Chemicals - Specialty
Compare Stocks
3 / 10Stock Comparison
AVNT vs FUL vs IOSP
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
AVNT vs FUL vs IOSP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $3.35B | $3.29B | $1.91B |
| Revenue (TTM) | $3.28B | $3.47B | $1.78B |
| Net Income (TTM) | $158M | $152M | $117M |
| Gross Margin | 31.7% | 31.5% | 27.7% |
| Operating Margin | 9.3% | 10.9% | 8.7% |
| Forward P/E | 12.0x | 12.9x | 15.5x |
| Total Debt | $1.92B | $2.02B | $90M |
| Cash & Equiv. | $511M | $107M | $293M |
AVNT vs FUL vs IOSP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
| H.B. Fuller Company (FUL) | 100 | 161.3 | +61.3% |
| Innospec Inc. (IOSP) | 100 | 99.4 | -0.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVNT vs FUL vs IOSP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVNT has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- Dividend streak 14 yrs, beta 1.19, yield 2.9%
- Rev growth 0.6%, EPS growth -51.6%, 3Y rev CAGR -1.4%
- 0.6% revenue growth vs IOSP's -3.7%
FUL is the clearest fit if your priority is momentum.
- +16.1% vs IOSP's -14.9%
IOSP is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 84.4% 10Y total return vs FUL's 54.5%
- Lower volatility, beta 0.70, Low D/E 6.7%, current ratio 2.79x
- PEG 0.48 vs FUL's 4.14
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.6% revenue growth vs IOSP's -3.7% | |
| Value | Lower P/E (12.0x vs 12.9x) | |
| Quality / Margins | 6.6% margin vs FUL's 4.4% | |
| Stability / Safety | Beta 0.70 vs FUL's 1.20, lower leverage | |
| Dividends | 2.9% yield, 14-year raise streak, vs FUL's 1.5% | |
| Momentum (1Y) | +16.1% vs IOSP's -14.9% | |
| Efficiency (ROA) | 6.5% ROA vs AVNT's 2.6%, ROIC 11.2% vs 3.9% |
AVNT vs FUL vs IOSP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AVNT vs FUL vs IOSP — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AVNT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FUL is the larger business by revenue, generating $3.5B annually — 2.0x IOSP's $1.8B. Profitability is closely matched — net margins range from 6.6% (IOSP) to 4.4% (FUL). On growth, AVNT holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $3.3B | $3.5B | $1.8B |
| EBITDAEarnings before interest/tax | $445M | $472M | $198M |
| Net IncomeAfter-tax profit | $158M | $152M | $117M |
| Free Cash FlowCash after capex | $205M | $121M | $88M |
| Gross MarginGross profit ÷ Revenue | +31.7% | +31.5% | +27.7% |
| Operating MarginEBIT ÷ Revenue | +9.3% | +10.9% | +8.7% |
| Net MarginNet income ÷ Revenue | +4.8% | +4.4% | +6.6% |
| FCF MarginFCF ÷ Revenue | +6.3% | +3.5% | +4.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | -3.1% | -2.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.8% | +122.2% | +167.7% |
Valuation Metrics
Evenly matched — AVNT and IOSP each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 16.4x trailing earnings, IOSP trades at a 60% valuation discount to AVNT's 41.0x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs FUL's 7.10x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $3.3B | $3.3B | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $4.8B | $5.2B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | 41.01x | 22.06x | 16.41x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.95x | 12.87x | 15.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 7.10x | 0.51x |
| EV / EBITDAEnterprise value multiple | 12.22x | 9.00x | 8.29x |
| Price / SalesMarket cap ÷ Revenue | 1.03x | 0.95x | 1.07x |
| Price / BookPrice ÷ Book value/share | 1.40x | 1.68x | 1.44x |
| Price / FCFMarket cap ÷ FCF | 17.16x | 27.11x | 21.68x |
Profitability & Efficiency
IOSP leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
IOSP delivers a 9.0% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $7 for AVNT. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to FUL's 1.01x. On the Piotroski fundamental quality scale (0–9), FUL scores 7/9 vs AVNT's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +6.6% | +7.6% | +9.0% |
| ROA (TTM)Return on assets | +2.6% | +2.9% | +6.5% |
| ROICReturn on invested capital | +3.9% | +7.8% | +11.2% |
| ROCEReturn on capital employed | +4.0% | +9.2% | +11.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.81x | 1.01x | 0.07x |
| Net DebtTotal debt minus cash | $1.4B | $1.9B | -$203M |
| Cash & Equiv.Liquid assets | $511M | $107M | $293M |
| Total DebtShort + long-term debt | $1.9B | $2.0B | $90M |
| Interest CoverageEBIT ÷ Interest expense | 3.61x | 2.62x | — |
Total Returns (Dividends Reinvested)
AVNT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FUL five years ago would be worth $9,342 today (with dividends reinvested), compared to $7,726 for AVNT. Over the past 12 months, FUL leads with a +16.1% total return vs IOSP's -14.9%. The 3-year compound annual growth rate (CAGR) favors AVNT at 0.8% vs IOSP's -6.1% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +16.0% | +1.3% | +0.5% |
| 1-Year ReturnPast 12 months | +4.1% | +16.1% | -14.9% |
| 3-Year ReturnCumulative with dividends | +2.3% | -4.3% | -17.3% |
| 5-Year ReturnCumulative with dividends | -22.7% | -6.6% | -18.3% |
| 10-Year ReturnCumulative with dividends | +27.8% | +54.5% | +84.4% |
| CAGR (3Y)Annualised 3-year return | +0.8% | -1.5% | -6.1% |
Risk & Volatility
Evenly matched — FUL and IOSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
IOSP is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than FUL's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FUL currently trades 88.4% from its 52-week high vs IOSP's 80.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.19x | 1.20x | 0.70x |
| 52-Week HighHighest price in past year | $44.85 | $68.63 | $95.55 |
| 52-Week LowLowest price in past year | $27.48 | $48.71 | $65.58 |
| % of 52W HighCurrent price vs 52-week peak | +81.4% | +88.4% | +80.2% |
| RSI (14)Momentum oscillator 0–100 | 55.2 | 49.9 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 620K | 569K | 221K |
Analyst Outlook
Evenly matched — AVNT and FUL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AVNT as "Buy", FUL as "Buy", IOSP as "Hold". Consensus price targets imply 50.1% upside for IOSP (target: $115) vs 20.9% for FUL (target: $73). For income investors, AVNT offers the higher dividend yield at 2.95% vs FUL's 1.50%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $48.40 | $73.33 | $115.00 |
| # AnalystsCovering analysts | 20 | 15 | 9 |
| Dividend YieldAnnual dividend ÷ price | +2.9% | +1.5% | +2.2% |
| Dividend StreakConsecutive years of raises | 14 | 23 | 12 |
| Dividend / ShareAnnual DPS | $1.08 | $0.91 | $1.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +1.8% | 0.0% |
AVNT leads in 2 of 6 categories (Income & Cash Flow, Total Returns). IOSP leads in 1 (Profitability & Efficiency). 3 tied.
AVNT vs FUL vs IOSP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AVNT or FUL or IOSP a better buy right now?
For growth investors, Avient Corporation (AVNT) is the stronger pick with 0.
6% revenue growth year-over-year, versus -3. 7% for Innospec Inc. (IOSP). Innospec Inc. (IOSP) offers the better valuation at 16. 4x trailing P/E (15. 5x forward), making it the more compelling value choice. Analysts rate Avient Corporation (AVNT) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVNT or FUL or IOSP?
On trailing P/E, Innospec Inc.
(IOSP) is the cheapest at 16. 4x versus Avient Corporation at 41. 0x. On forward P/E, Avient Corporation is actually cheaper at 12. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 48x versus H. B. Fuller Company's 4. 14x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — AVNT or FUL or IOSP?
Over the past 5 years, H.
B. Fuller Company (FUL) delivered a total return of -6. 6%, compared to -22. 7% for Avient Corporation (AVNT). Over 10 years, the gap is even starker: IOSP returned +84. 4% versus AVNT's +27. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVNT or FUL or IOSP?
By beta (market sensitivity over 5 years), Innospec Inc.
(IOSP) is the lower-risk stock at 0. 70β versus H. B. Fuller Company's 1. 20β — meaning FUL is approximately 72% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 101% for H. B. Fuller Company — giving it more financial flexibility in a downturn.
05Which is growing faster — AVNT or FUL or IOSP?
By revenue growth (latest reported year), Avient Corporation (AVNT) is pulling ahead at 0.
6% versus -3. 7% for Innospec Inc. (IOSP). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -51. 6% for Avient Corporation. Over a 3-year CAGR, AVNT leads at -1. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVNT or FUL or IOSP?
Innospec Inc.
(IOSP) is the more profitable company, earning 6. 6% net margin versus 2. 5% for Avient Corporation — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FUL leads at 11. 5% versus 6. 2% for AVNT. At the gross margin level — before operating expenses — AVNT leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVNT or FUL or IOSP more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 48x versus H. B. Fuller Company's 4. 14x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Avient Corporation (AVNT) trades at 12. 0x forward P/E versus 15. 5x for Innospec Inc. — 3. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 50. 1% to $115. 00.
08Which pays a better dividend — AVNT or FUL or IOSP?
All stocks in this comparison pay dividends.
Avient Corporation (AVNT) offers the highest yield at 2. 9%, versus 1. 5% for H. B. Fuller Company (FUL).
09Is AVNT or FUL or IOSP better for a retirement portfolio?
For long-horizon retirement investors, Innospec Inc.
(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 2% yield). Both have compounded well over 10 years (IOSP: +84. 4%, AVNT: +27. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVNT and FUL and IOSP?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AVNT is a small-cap quality compounder stock; FUL is a small-cap quality compounder stock; IOSP is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.